Skip to main content

Month: June 2023

Decisions of annual general shareholder meeting, AB Novaturas

On 6th of June, 2023 annual general meeting of AB Novaturas had taken place.  Shareholders representing 4 172 117 shares ( 53.44 % from total issued 7 807 000) were present in the meeting.  The meeting had accepted the following decisions:Approved Company‘s stand alone and consolidated financial reporting package for the year ended 31 December 2022. Approved Company’s remuneration statement which has been presented within the scope of  consolidated annual report for the year ended 31 December 2022. Approved draft profit appropriation, as presented below (amounts are in thousand Euros):1) Undistributed result – profit (loss) of the previous financial year at the end of the accounting financial year 10 4542) Net profit (loss) of the accounting financial year (713)3) Dividends paid during year 2022 04) Profit (loss) for the...

Continue reading

Grieg Seafood ASA: Notice of the annual general meeting 2023

The annual general meeting of Grieg Seafood ASA will be virtually held on Tuesday, 27 June 2023 at 3:00 pm CEST. The notice is attached both in Norwegian and English language. The integrated annual report 2022, including the sustainability report and the financial accounts, was published via a stock exchange release on 31 March 2023 and is available at https://investor.griegseafood.com/reports-&-presentations#annual This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.AttachmentsGSF ASA Innkalling til generalforsamling 2023GSF ASA Innkalling til generalforsamling 2023GSF ASA Notice of annual general meeting 2023GSF ASA Notice of annual general meeting 2023

Continue reading

TransPerfect Legal Solutions Acquires eDepoze to Streamline Remote Depositions

Company Expects to Increase Investment in Deposition Technology Platforms NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) — TransPerfect Legal Solutions (TLS), a global provider of e-discovery and litigation support solutions for law firms and corporate legal departments, today announced its acquisition of the electronic exhibit-sharing platform eDepoze. Financial terms were not disclosed. The acquisition of eDepoze supplements TransPerfect Legal Solutions’ deposition services offerings and provides clients with an industry-leading electronic exhibit-sharing platform that simplifies workflows for examination before trial (EBT) requirements, including remote and in-person depositions. eDepoze is integrated with Zoom and provides users with a centralized location to store their exhibits and present them during depositions and hearings in...

Continue reading

Teledyne’s backside illuminated TDI camera delivers greater sensitivity for near ultraviolet and visible imaging

Teledyne DALSA’s Linea HS 16k BSI camera The new Linea HS 16k BSI camera is ideal for near ultraviolet and visible imaging applicationsWATERLOO, Ontario, June 06, 2023 (GLOBE NEWSWIRE) — Teledyne DALSA, a Teledyne Technologies [NYSE:TDY] company, is pleased to announce its Linea™ HS 16k Backside Illuminated (BSI) TDI camera is in production now. With its CLHS interface, this camera offers enhanced sensitivity and is ideal for Near Ultraviolet (NUV) and visible imaging applications such as wafer, flat panel display and electronic packaging inspection as well as photoluminescence and life science imaging. The new Linea HS 16k BSI uses Teledyne DALSA’s charge-domain CMOS TDI 16k sensor with a 5×5 μm pixel size and delivers a maximum line rate of 400 kHz aggregate. Compared with Front Side Illumination (FSI), the...

Continue reading

Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions

Appoints Paul Michaels Co-CEO of Parent and CEO of Subsidiary Boca Raton, FL, June 06, 2023 (GLOBE NEWSWIRE) — Curative Biotechnology Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel therapies for rare diseases and conditions, today announced that the registration process has begun for the creation of a subsidiary in Japan with an official incorporation date expected August 1, 2023, to facilitate licensing transactions and asset licensing within the country. The establishment of this subsidiary marks an important milestone for Curative Biotech as it expands its reach and presence in the Japanese market. The new entity has been named Curative Biotech Japan K.K. (“Curative Japan”) and will be located at 2-23-12 Shimomeguro Meguro ku, Tokyo 153-0064 Japan. The Company...

Continue reading

[Latest News] North America Pulp and Paper Market to Worth $65.10 Bn by 2029 | With 0.13% CAGR

The global North America pulp and paper market covered major segments by Category (Wrapping & Packaging, Printing & Writing, Sanitary, News Print, and Others), and Country Forecast, 2023-2029 Pune, India, June 06, 2023 (GLOBE NEWSWIRE) — According to a report published by Fortune Business Insights™ states, The North America pulp and paper market size garnered USD 64.32 billion in 2021 and is projected to grow from USD 64.51 billion in 2022 to USD 65.10 billion by 2029 at a 0.13% CAGR during the forecast period. Fortune Business Insights™ has elucidated these inputs in its latest research report, titled, “North America Pulp and Paper Market, 2023-2029.” Pulp and paper refer to the materials and the industry involved in the production of paper and related products. The pulp and paper industry plays a significant...

Continue reading

OKYO Pharma Announces Randomized Segment Now Underway in Phase 2 Clinical Trial of Topical Ocular OK-101 for Dry Eye Disease

Trial designed with a two-week run-in period to reduce the well-known placebo effect in trials involving pain component Top-line data from trial anticipated in Q4, 2023LONDON and NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (DED) to address the significant unmet need in this multi-billion-dollar market, is pleased to announce that patients are now being dosed in the randomized portion of the phase 2, multi-center, double-masked, placebo-controlled trial of topical ocular OK-101 to treat DED, following the two-week placebo run-in period intended to minimize the placebo effect. “A two-week placebo run-in period involving topical ocular dosing of placebo is an innovative approach used by our...

Continue reading

Ozop Energy Solutions, Inc. to Attend NIADA in Los Vegas

Ozop Plus and Royal Administration Services Inc. to Showcase Fully Charged VSC Warwick, NY, June 06, 2023 (GLOBE NEWSWIRE) — Ozop Plus, a subsidiary of Ozop Energy Solutions, Inc. (OZSC or the “Company”), announces that it will be attending the upcoming National Independent Automobile Dealers Association (NIADA) convention at the Wynn Hotel in Las Vegas June 19-22. We will be participating in the show with Royal Administration, Inc. (Royal). This collaboration at the NIADA convention will provide a unique opportunity for Ozop Plus and Royal to showcase their innovative Fully Charged vehicle service contract for EV Vehicles with comprehensive battery coverage to a diverse audience of automotive professionals. The NIADA convention is an annual event that serves as a premier gathering for automotive professionals, industry leaders,...

Continue reading

ALSTOM S.A: 2022/23 Universal Registration Document available

 6 June 2023 – Alstom’s 2022/23 Universal Registration Document, which includes notably the Annual Financial Report, was filed with the “Autorité des marchés financiers” (AMF) on 6 June 2023. This document is available to the public free of charge in accordance with applicable regulation and may be viewed on Alstom’s website (https://www.alstom.com/finance), as well as on the AMF website (www.amf-france.org). The following information is included in the 2022/23 Universal Registration Document:the Annual Financial Report, including notably the consolidated financial statements, the statutory accounts, the related Statutory Auditors’ reports and the management report, the Board of Directors’ report on corporate governance, the Statutory Auditors’ special report on related-party agreements...

Continue reading

Crown Electrokinetics Completes Restructuring of Balance Sheet

LOS ANGELES, June 06, 2023 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company and an expert in both designing and installing distributed antenna systems (DAS) and constructing fiber optic networks, today announced that it has entered into a series of agreements with existing shareholders and note holders. Crown has established a new series of Preferred stock and taken the appropriate steps to repay, retire, or exchange all of its existing debt notes for the new preferred equity. Additionally, the Line of Credit will be paid down. The retirement of existing debt, including the $5.4 million convertible note issued in October 2022, will also allow the company to operate without restrictive covenants typically associated with convertible...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.